SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950138-17-000031
Filing Date
2017-01-05
Accepted
2017-01-05 16:26:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 sch13da20_01052017.htm SC 13D/A 140952
  Complete submission text file 0000950138-17-000031.txt   142297
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Subject) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53249 | Film No.: 17511053
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address
Business Address 7575 FULTON STREET EAST ADA MI 49355-0001
PYXIS INNOVATIONS INC (Filed by) CIK: 0001221575 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A